A phase Ib trial of IPI-504 (retaspimycin hydrochloride), a novel Hsp90 inhibitor, in combination with docetaxel Meeting Abstract
| Authors: | Riely, G. J.; Stoller, R.; Egorin, M.; Solit, D.; Dunbar, J.; Savage, A.; Walker, J.; Grayzel, D.; Ross, R.; Weiss, G. J. |
| Abstract Title: | A phase Ib trial of IPI-504 (retaspimycin hydrochloride), a novel Hsp90 inhibitor, in combination with docetaxel |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 157s |
| Language: | English |
| ACCESSION: | WOS:000276606602437 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.3547 |
| Notes: | Meeting Abstract: 3547 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
